Could pharma, digital therapeutics partnerships be a $1B opportunity?
A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were "a match made in heaven."
A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were "a match made in heaven."
Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.